On Thursday 31st October 2024, Takeda Pharmaceutical Company Limited (NYSE: TAK) will be releasing its second quarter financial results. This much awaited announcement will be made before market open.
It is anticipated by financial experts on Wall Street that the organization is set to announce an estimated $0.57 profit per share for the quarter. Additionally, the firm is expected to disclose a total revenue of $7.08 million for this period.
During the same quarter of the previous year, the company's earnings report indicated a per-share income of $0.48. Moreover, the company generated a total revenue of $6.34 billion during that specific quarter.
Wall Street analysts have offered their forecasts for the company's yearly performance, predicting a total revenue of $28.7 million. At the same time, they are expecting the company to achieve per share profit of $0.35 for the fiscal year ahead.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q1 2024 | $0.56 | +7.7% | 7.75 B | +5.8% |
| Q4 2023 | $0.24 | -38.5% | 7.08 B | -2.0% |
| Q3 2023 | $0.51 | -13.6% | 7.89 B | -18.3% |
| Q2 2023 | $0.48 | -7.7% | 6.34 B | -12.6% |
| Q1 2023 | $0.52 | -7.1% | 7.33 B | -2.4% |
| *Growth on year-over-year basis | ||||
Takeda Pharmaceutical Company Limited (TAK) experienced a trading range of $13.67 to $13.88, along with a total volume of 1.55 million shares during the day. The stock concluded Tuesday's regular trading session at $13.85, indicating an advance of 1.84 percent.
